Results 171 to 180 of about 208,148 (266)

Comparison of remission rates in Egyptian patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors below the age of fifty

Family Medicine & Primary Care Review
Mohamed Said Abd Elwahab, Nermein Sayed Abd Elaziz, Nehad Mohamed Tawfeek, Moataz Fathy Mohamed, Ibrahem Ahmed Ibrahem   +4 more
doaj   +1 more source

Bosutinib-Induced Pleural Effusion-Class Effect and Cross-Intolerance to All Tyrosine Kinase Inhibitors. [PDF]

Hematol Rep
Vojjala N, Sami HA, Kotla NK, Peshin S, Goyal K, Kondaveety S, Prabhu RR, Krishnamoorthy G.   +7 more
europepmc   +1 more source

Patient rights in precision oncology: right treatment, right time, right dose, right order, right place. [PDF]

Genome Med
Fountzilas E, Tsimberidou AM, Kurzrock R.   +2 more
europepmc   +1 more source

Formation of multiple G-quadruplexes contributes toward BCR fragility associated with chronic myelogenous leukemia. [PDF]

Nucleic Acids Res
Sharma S, Thomas E, Dahal S, Das S, Kothari S, Roy U, Kumari N, Gopalakrishnan V, Raghavan SC.   +8 more
europepmc   +1 more source

No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the <i>BCR::ABL1</i> Transcript Level. [PDF]

Int J Mol Sci
Stagno F, Stella S, Leotta S, Caserta S, Vitale SR, Markovic U, Tomarchio C, Mirabile G, Russo S, Massimino M, Vigneri P, Manzella L, Di Raimondo F, Allegra A.   +13 more
europepmc   +1 more source

Treatment-Emergent Resistance to Asciminib in Chronic Myeloid Leukemia Patients Due to Myristoyl-Binding Pocket-Mutant of <i>BCR::ABL1/A337V</i> Can Be Effectively Overcome with Dasatinib Treatment. [PDF]

Curr Oncol
Batar P, Mezei G, Illes A.
europepmc   +1 more source

Chronic myelogenous leukemia secondary to colon cancer: A case report. [PDF]

World J Gastrointest Oncol
Li XL, Li M, Yang H, Tian J, Shi ZW, Wang LZ, Song K.   +6 more
europepmc   +1 more source

Impact of national volume-based procurement policy on drugs treating chronic Myelogenous Leukemia. [PDF]

J Health Popul Nutr
Yang Z, Li Y, Liu S, Han X, Wu Y, Fan X, Li Y, Jiang B.   +7 more
europepmc   +1 more source

Effects of the novel aurora kinase/JAK inhibitor, AT9283 and imatinib on Philadelphia positive cells in vitro [PDF]

, 2012
Arkenau, Baccarani, Corbin, Hamilton, Heather Jørgensen, Hiwase, John Lyons, Kimura, Kubonishi, Mohsin Shah, Paolo Gallipoli, Tanaka, Tessa Holyoake, Vigneri, Wang, Zouein   +15 more
core   +1 more source

Structure and Dynamics of the ABL1 Tyrosine Kinase and Its Important Role in Chronic Myeloid Leukemia. [PDF]

Arch Pharm (Weinheim)
Irgit A, Kamıs R, Sever B, Tuyun AF, Otsuka M, Fujita M, Demirci H, Ciftci H.   +7 more
europepmc   +1 more source